Overview
Jelena Kao is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Kao is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Essential Thrombocythemia, and Pleuropulmonary Blastoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave, San Francisco, CA 94143
Stanford Medicine Cancer Center
Jason Gotlib is a Hematologist in Palo Alto, California. Dr. Gotlib is rated as an Elite provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Systemic Mastocytosis, Mast Cell Activation Syndrome (MCAS), Myelofibrosis, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Gotlib is currently accepting new patients.
Stanford Health Care
Peter Galatin is an Oncologist and a Hematologist in Stanford, California. Dr. Galatin is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Polycythemia Vera, Essential Thrombocythemia, Chronic Lymphocytic Leukemia (CLL), and Small Lymphocytic Lymphoma (SLL).
University Of California San Francisco
Catherine Smith is a Hematologist and an Oncologist in San Francisco, California. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Essential Thrombocythemia, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Myelofibrosis, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Kao isDistinguished. Learn about Breast Cancer.
- Essential ThrombocythemiaDr. Kao isDistinguished. Learn about Essential Thrombocythemia.
- Paget Disease of the BreastDr. Kao isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Acute Eosinophilic Pneumonia
- AnemiaDr. Kao isAdvanced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Kao isAdvanced. Learn about Autoimmune Hemolytic Anemia.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Ewing SarcomaDr. Kao isAdvanced. Learn about Ewing Sarcoma.
- Familial Pancreatic CancerDr. Kao isAdvanced. Learn about Familial Pancreatic Cancer.
- Experienced
- Acquired AgranulocytosisDr. Kao isExperienced. Learn about Acquired Agranulocytosis.
- Acute Mountain SicknessDr. Kao isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Kao isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Kao isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Kao isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer